Broadening of Virus-Specific CD8 T-Cell Responses Is Indicative of Residual Viral Replication in Aviremic SIV Controllers

English version České info

CD8+ T-cell responses are crucial for HIV control, but it is unclear whether lasting HIV containment can be achieved after establishment of infection. Several T cell-based vaccine trials have currently shown primary viremia control in macaque AIDS models of simian immunodeficiency virus (SIV) infection, but residual viral replication may occur, followed by accumulation of viral CD8+ T-cell escape mutations, possibly leading to eventual viremia rebound. In the present study, we analyzed ten rhesus macaques that controlled SIV replication without detectable viremia for more than 2 years. Animals were divided into two groups on the basis of proviral genome sequences at 2 years post-infection. Analysis of the first group exhibiting multiple CD8+ T-cell escape mutations indicated that broadening of CD8+ T-cell responses can be an indicator of the beginning of viral control failure. Conversely, analysis of the second group having no mutation suggested that stability of the breadth of virus-specific CD8+ T-cell responses represents a status of lasting HIV containment by CD8+ T cells. Thus, this study presents a model of stable SIV containment, contributing to elucidation of the requisites for lasting HIV control.

Vyšlo v časopise: Broadening of Virus-Specific CD8 T-Cell Responses Is Indicative of Residual Viral Replication in Aviremic SIV Controllers. PLoS Pathog 11(11): e32767. doi:10.1371/journal.ppat.1005247
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1005247

Souhrn

Zdroje

1. Rosenberg E.S., Altfeld M., Poon S.H., Phillips M.N., Wilkes B.M., Eldridge R.L., Robbins G.K., D'Aquila R.T., Goulder P.J., and Walker B.D. (2000). Immune control of HIV-1 after early treatment of acute infection. Nature 407, 523–526. 11029005

2. Ortiz G.M., Wellons M., Brancato J., Vo H.T., Zinn R.L., Clarkson D.E., Van Loon K., Bonhoeffer S., Miralles G.D., Montefiori D., et al. (2001). Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects. Proc. Natl. Acad. Sci. U. S. A. 98, 13288–13293. 11687611

3. Hocqueloux L., Prazuck T., Avettand-Fenoel V., Lafeuillade A., Cardon B., Viard J.P., and Rouzioux C. (2010). Long-term immunovirologic control following antiretroviral therapy interruption in patients treated at the time of primary HIV-1 infection. AIDS 24, 1598–1601. 20549847

4. Saez-Cirion A., Bacchus C., Hocqueloux L., Avettand-Fenoel V., Girault I., Lecuroux C., Potard V., Versmisse P., Melard A., Prazuck T., et al. (2013). Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study. PLoS Pathog. 9, e1003211. doi: 10.1371/journal.ppat.1003211 23516360

5. Roederer M., Keele B.F., Schmidt S.D., Mason R.D., Welles H.C., Fischer W., Labranche C., Foulds K.E., Louder M.K., Yang Z.Y., et al. (2014). Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV. Nature 505, 502–508. doi: 10.1038/nature12893 24352234

6. Barouch D.H., Whitney J.B., Moldt B., Klein F., Oliveira T.Y., Liu J., Stephenson K.E., Chang H.W., Shekhar K., Gupta S., et al. (2013). Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys. Nature 503, 224–228. doi: 10.1038/nature12744 24172905

7. Koup R.A., Safrit J.T., Cao Y., Andrews C.A., McLeod G., Borkowsky W., Farthing C., and Ho D.D. (1994). Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68, 4650–4655. 8207839

8. Borrow P., Lewicki H., Hahn B.H., Shaw G.M., and Oldstone M.B. (1994). Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68, 6103–6110. 8057491

9. Matano T., Shibata R., Siemon C., Connors M., Lane H.C., and Martin M.A. (1998). Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques. J. Virol. 72, 164–169. 9420212

10. Jin X., Bauer D.E., Tuttleton S.E., Lewin S., Gettie A., Blanchard J., Irwin C.E., Safrit J.T., Mittler J., Weinberger L., et al. (1999). Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J. Exp. Med. 189, 991–998. 10075982

11. Schmitz J.E., Kuroda M.J., Santra S., Sasseville V.G., Simon M.A., Lifton M.A., Racz P., Tenner-Racz K., Dalesandro M., Scallon B.J., et al. (1999). Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 283, 857–860. 9933172

12. Migueles S.A., Sabbaghian M.S., Shupert W.L., Bettinotti M.P., Marincola F.M., Martino L., Hallahan C.W., Selig S.M., Schwartz D., Sullivan J., et al. (2000). HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc. Natl. Acad. Sci. U. S. A. 97, 2709–2714. 10694578

13. Tang J., Tang S., Lobashevsky E., Myracle A.D., Fideli U., Aldrovandi G., Allen S., Musonda R., Kaslow R.A., and Zambia, U.A.B.H.I.V.R.P. (2002). Favorable and unfavorable HLA class I alleles and haplotypes in Zambians predominantly infected with clade C human immunodeficiency virus type 1. J. Virol. 76, 8276–8284. 12134033

14. Kiepiela P., Leslie A.J., Honeyborne I., Ramduth D., Thobakgale C., Chetty S., Rathnavalu P., Moore C., Pfafferott K.J., Hilton L., et al. (2004). Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 432, 769–775. 15592417

15. Goulder P.J., and Watkins D.I. (2008). Impact of MHC class I diversity on immune control of immunodeficiency virus replication. Nat. Rev. Immunol. 8, 619–630. doi: 10.1038/nri2357 18617886

16. Bontrop R.E., and Watkins D.I. (2005). MHC polymorphism: AIDS susceptibility in non-human primates. Trends. Immunol. 26, 227–233. 15797514

17. Yant L.J., Friedrich T.C., Johnson R.C., May G.E., Maness N.J., Enz A.M., Lifson J.D., O'Connor D.H., Carrington M., and Watkins D.I. (2006). The high-frequency major histocompatibility complex class I allele Mamu-B*17 is associated with control of simian immunodeficiency virus SIVmac239 replication. J. Virol. 80, 5074–5077. 16641299

18. Loffredo J.T., Maxwell J., Qi Y., Glidden C.E., Borchardt G.J., Soma T., Bean A.T., Beal D.R., Wilson N.A., Rehrauer W.M., et al. (2007). Mamu-B*08-positive macaques control simian immunodeficiency virus replication. J. Virol. 81, 8827–8832. 17537848

19. Altfeld M., Addo M.M., Rosenberg E.S., Hecht F.M., Lee P.K., Vogel M., Yu X.G., Draenert R., Johnston M.N., Strick D., et al. (2003). Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection. AIDS 17, 2581–2591. 14685052

20. Altfeld M., Kalife E.T., Qi Y., Streeck H., Lichterfeld M., Johnston M.N., Burgett N., Swartz M.E., Yang A., Alter G., et al. (2006). HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1. PLoS Med. 3, e403. 17076553

21. Schneidewind A., Brockman M.A., Yang R., Adam R.I., Li B., Le Gall S., Rinaldo C.R., Craggs S.L., Allgaier R.L., Power K.A., et al. (2007). Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication. J. Virol. 81, 12382–12393. 17804494

22. Goulder P.J., Phillips R.E., Colbert R.A., McAdam S., Ogg G., Nowak M.A., Giangrande P., Luzzi G., Morgan B., Edwards A., et al. (1997). Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat. Med. 3, 212–217. 9018241

23. Feeney M.E., Tang Y., Roosevelt K.A., Leslie A.J., McIntosh K., Karthas N., Walker B.D., and Goulder P.J. (2004). Immune escape precedes breakthrough human immunodeficiency virus type 1 viremia and broadening of the cytotoxic T-lymphocyte response in an HLA-B27-positive long-term-nonprogressing child. J. Virol. 78, 8927–8930. 15280502

24. Goulder P.J., and Watkins D.I. (2004). HIV and SIV CTL escape: implications for vaccine design. Nat. Rev. Immunol. 4, 630–640. 15286729

25. Kawada M., Igarashi H., Takeda A., Tsukamoto T., Yamamoto H., Dohki S., Takiguchi M., and Matano T. (2006). Involvement of multiple epitope-specific cytotoxic T-lymphocyte responses in vaccine-based control of simian immunodeficiency virus replication in rhesus macaques. J. Virol. 80, 1949–1958. 16439550

26. Matano T., Kobayashi M., Igarashi H., Takeda A., Nakamura H., Kano M., Sugimoto C., Mori K., Iida A., Hirata T., et al. (2004). Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial. J. Exp. Med. 199, 1709–1718. 15210746

27. Liu J., O'Brien K.L., Lynch D.M., Simmons N.L., La Porte A., Riggs A.M., Abbink P., Coffey R.T., Grandpre L.E., Seaman M.S., et al. (2009). Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys. Nature 457, 87–91. doi: 10.1038/nature07469 18997770

28. Hansen S.G., Ford J.C., Lewis M.S., Ventura A.B., Hughes C.M., Coyne-Johnson L., Whizin N., Oswald K., Shoemaker R., Swanson T., et al. (2011). Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine. Nature 473, 523–527. doi: 10.1038/nature10003 21562493

29. Mudd P.A., Martins M.A., Ericsen A.J., Tully D.C., Power K.A., Bean A.T., Piaskowski S.M., Duan L., Seese A., Gladden A.D., et al. (2012). Vaccine-induced CD8+ T cells control AIDS virus replication. Nature 491, 129–133. doi: 10.1038/nature11443 23023123

30. Matano T., Kano M., Nakamura H., Takeda A., and Nagai Y. (2001). Rapid appearance of secondary immune responses and protection from acute CD4 depletion after a highly pathogenic immunodeficiency virus challenge in macaques vaccinated with a DNA prime/Sendai virus vector boost regimen. J. Virol. 75, 11891–11896. 11689672

31. Kawada M., Tsukamoto T., Yamamoto H., Iwamoto N., Kurihara K., Takeda A., Moriya C., Takeuchi H., Akari H., and Matano T. (2008). Gag-specific cytotoxic T-lymphocyte-based control of primary simian immunodeficiency virus replication in a vaccine trial. J. Virol. 82, 10199–10206. doi: 10.1128/JVI.01103-08 18667518

32. Naruse T.K., Chen Z., Yanagida R., Yamashita T., Saito Y., Mori K., Akari H., Yasutomi Y., Miyazawa M., Matano T., et al. (2010). Diversity of MHC class I genes in Burmese-origin rhesus macaques. Immunogenetics 62, 601–611. doi: 10.1007/s00251-010-0462-z 20640416

33. Nomura T., Yamamoto H., Shiino T., Takahashi N., Nakane T., Iwamoto N., Ishii H., Tsukamoto T., Kawada M., Matsuoka S., et al. (2012). Association of major histocompatibility complex class I haplotypes with disease progression after simian immunodeficiency virus challenge in burmese rhesus macaques. J. Virol. 86, 6481–6490. doi: 10.1128/JVI.07077-11 22491464

34. Nomura T., Yamamoto H., Takahashi N., Naruse T.K., Kimura A., and Matano T. (2014). Identification of SIV Nef CD8(+) T cell epitopes restricted by a MHC class I haplotype associated with lower viral loads in a macaque AIDS model. Biochem. Biophys. Res. Commun. 450, 942–947. doi: 10.1016/j.bbrc.2014.06.072 24971540

35. Tsukamoto T., Takeda A., Yamamoto T., Yamamoto H., Kawada M., and Matano T. (2009). Impact of cytotoxic-T-lymphocyte memory induction without virus-specific CD4+ T-Cell help on control of a simian immunodeficiency virus challenge in rhesus macaques. J. Virol. 83, 9339–9346. doi: 10.1128/JVI.01120-09 19587045

36. Ishii H., Kawada M., Tsukamoto T., Yamamoto H., Matsuoka S., Shiino T., Takeda A., Inoue M., Iida A., Hara H., et al. (2012). Impact of vaccination on cytotoxic T lymphocyte immunodominance and cooperation against simian immunodeficiency virus replication in rhesus macaques. J. Virol. 86, 738–745. doi: 10.1128/JVI.06226-11 22072784

37. Moriya C., Igarashi H., Takeda A., Tsukamoto T., Kawada M., Yamamoto H., Inoue M., Iida A., Shu T., Hasegawa M., et al. (2008). Abrogation of AIDS vaccine-induced cytotoxic T-lymphocyte efficacy in vivo due to a change in viral epitope flanking sequences. Microbes Infect. 10, 285–292. doi: 10.1016/j.micinf.2007.12.002 18316225

38. Sheehy A.M., Gaddis N.C., Choi J.D., and Malim M.H. (2002). Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418, 646–650. 12167863

39. Harris R.S., Bishop K.N., Sheehy A.M., Craig H.M., Petersen-Mahrt S.K., Watt I.N., Neuberger M.S., and Malim M.H. (2003). DNA deamination mediates innate immunity to retroviral infection. Cell 113, 803–809. 12809610

40. Zennou V., and Bieniasz P.D. (2006). Comparative analysis of the antiretroviral activity of APOBEC3G and APOBEC3F from primates. Virology 349, 31–40. 16460778

41. Fourati S., Lambert-Niclot S., Soulie C., Malet I., Valantin M.A., Descours B., Ait-Arkoub Z., Mory B., Carcelain G., Katlama C., et al. (2012). HIV-1 genome is often defective in PBMCs and rectal tissues after long-term HAART as a result of APOBEC3 editing and correlates with the size of reservoirs. J. Antimicrob. Chemother. 67, 2323–2326. doi: 10.1093/jac/dks219 22687892

42. Eisele E., and Siliciano R.F. (2012). Redefining the viral reservoirs that prevent HIV-1 eradication. Immunity 37, 377–388. doi: 10.1016/j.immuni.2012.08.010 22999944

43. Whitney J.B., Hill A.L., Sanisetty S., Penaloza-MacMaster P., Liu J., Shetty M., Parenteau L., Cabral C., Shields J., Blackmore S., et al. (2014). Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys. Nature 512, 74–77. doi: 10.1038/nature13594 25042999

44. Hansen S.G., Piatak M. Jr., Ventura A.B., Hughes C.M., Gilbride R.M., Ford J.C., Oswald K., Shoemaker R., Li Y., Lewis M.S., et al. (2013). Immune clearance of highly pathogenic SIV infection. Nature 502, 100–104. doi: 10.1038/nature12519 24025770

45. Eriksson S., Graf E.H., Dahl V., Strain M.C., Yukl S.A., Lysenko E.S., Bosch R.J., Lai J., Chioma S., Emad F., et al. (2013). Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies. PLoS Pathog. 9, e1003174. doi: 10.1371/journal.ppat.1003174 23459007

46. Ho Y.C., Shan L., Hosmane N.N., Wang J., Laskey S.B., Rosenbloom D.I., Lai J., Blankson J.N., Siliciano J.D., and Siliciano R.F. (2013). Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure. Cell 155, 540–551. doi: 10.1016/j.cell.2013.09.020 24243014

47. Ndhlovu Z.M., Proudfoot J., Cesa K., Alvino D.M., McMullen A., Vine S., Stampouloglou E., Piechocka-Trocha A., Walker B.D., Pereyra F. (2012). Elite controllers with low to absent effector CD8+ T cell responses maintain highly functional, broadly directed central memory responses. J. Virol. 86, 6959–6969. doi: 10.1128/JVI.00531-12 22514340

48. Budde M.L., Greene J.M., Chin E.N., Ericsen A.J., Scarlotta M., Cain B.T., Pham N.H., Becker E.A., Harris M., Weinfurter J.T., et al. (2012). Specific CD8+ T cell responses correlate with control of simian immunodeficiency virus replication in Mauritian cynomolgus macaques. J. Virol. 86, 7596–7604 doi: 10.1128/JVI.00716-12 22573864

49. Radebe M., Gounder K., Mokgoro M., Ndhlovu Z.M., Mncube Z., Mkhize L., van der Stok M., Jaggernath M., Walker B.D., Ndung'u T. (2015). Broad and persistent Gag-specific CD8+ T-cell responses are associated with viral control but rarely drive viral escape during primary HIV-1 infection. AIDS 29, 23–33. doi: 10.1097/QAD.0000000000000508 25387316

50. Deng K., Pertea M., Rongvaux A., Wang L., Durand C.M., Ghiaur G., Lai J., McHugh H.L., Hao H., Zhang H., et al. (2015). Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations. Nature 517, 381–385. doi: 10.1038/nature14053 25561180

51. Hansen S.G., Sacha J.B., Hughes C.M., Ford J.C., Burwitz B.J., Scholz I., Gilbride R.M., Lewis M.S., Gilliam A.N., Ventura A.B., et al. (2013). Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigms. Science 340, 1237874. doi: 10.1126/science.1237874 23704576

52. Kestler H.W. 3rd, Ringler D.J., Mori K., Panicali D.L., Sehgal P.K., Daniel M.D., and Desrosiers R.C. (1991). Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65, 651–662. 2032289

53. Iwamoto N., Takahashi N., Seki S., Nomura T., Yamamoto H., Inoue M., Shu T., Naruse T.K., Kimura A., and Matano T. (2014). Control of simian immunodeficiency virus replication by vaccine-induced Gag- and Vif-specific CD8+ T cells. J. Virol. 88, 425–433. doi: 10.1128/JVI.02634-13 24155398